IBIO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

iBio, Inc. Common Stock

NYSE MKT | IBIO

1.11

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 21, 2025)

$18.09M

Market Cap

-

P/E Ratio

-1.84

EPS

$6.89

52 Week High

$0.56

52 Week Low

HEALTHCARE

Sector

IBIO Chart

Recent Chart
Price Action

IBIO Technicals

Tags:

IBIO Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -
Total Revenue $400K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$18M
Selling General And Administrative $11M
Research And Development $8.3M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $225K
Interest Income $437K
Interest Expense -$212K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$18M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda -$18M
Net Income -$18M

Revenue & Profitability

Earnings Performance

IBIO Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $23M
Total Current Assets $9.7M
Cash And Cash Equivalents At Carrying Value $8.6M
Cash And Short Term Investments $8.6M
Inventory -
Current Net Receivables -
Total Non Current Assets $13M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $6.8M
Intangible Assets Excluding Goodwill $6.8M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.1M
Other Non Current Assets -
Total Liabilities $8.3M
Total Current Liabilities $6.1M
Current Accounts Payable $2.2M
Deferred Revenue -
Current Debt -
Short Term Debt $543K
Total Non Current Liabilities $2.2M
Capital Lease Obligations $2.7M
Long Term Debt -
Current Long Term Debt $766K
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.7M
Other Current Liabilities $3.4M
Other Non Current Liabilities -
Total Shareholder Equity $15M
Treasury Stock -
Retained Earnings -$332M
Common Stock $19K
Common Stock Shares Outstanding $10M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$15M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $291K
Capital Expenditures $16K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $742K
Cashflow From Financing $8.9M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$18M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -
Total Revenue $400K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$18M
Selling General And Administrative $11M
Research And Development $8.3M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $225K
Interest Income $437K
Interest Expense -$212K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$18M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda -$18M
Net Income -$18M

IBIO Profile

iBio, Inc. Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

iBio, Inc. is a pioneering biotechnology firm specializing in plant-based biopharmaceutical production, headquartered in New York. The company offers contract development and manufacturing services for biologics, focusing on vaccines and therapeutics, thereby serving as a vital partner for organizations in the United States and internationally. With its proprietary technologies, iBio is dedicated to improving efficiency and scalability in the biologics manufacturing process, addressing the increasing demand for sustainable and cost-effective solutions in the rapidly evolving life sciences sector.

BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+29.73%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.26%
$26.03
AIRE
+61.36%
$0.72
NVTS
+16.64%
$17.10
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.27%
$13.38
DVLT
0.00%
$2.41
IBIO
+24.30%
$1.11
RIG
+0.45%
$3.30
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ETHD
-0.53%
$3.73
ABEV
-2.42%
$2.21
TSLA
-1.07%
$442.60
RF
+1.22%
$24.35
ABAT
+38.55%
$6.72
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.84%
$11.40
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
LAES
-8.46%
$5.93
VALE
-1.22%
$11.26
BTBT
-8.29%
$3.87
NEHC
+23.95%
$5.64
PFE
+0.64%
$24.85
QBTS
-6.36%
$32.21
IREN
-6.79%
$55.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
HAL
+11.53%
$25.23
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
DFLI
-3.96%
$1.21
AAPL
+0.38%
$263.26
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.45%
$51.94
KO
+4.10%
$71.25
ORCL
-4.85%
$277.18
SNAP
+1.68%
$7.86
PBR
-1.06%
$11.56
AMC
+3.61%
$2.87
NOK
-1.92%
$5.60
SMR
-13.23%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
MSN
+70.10%
$0.81
BYND
+146.25%
$3.62
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
VHAI
0.00%
$0.00
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
GDXD
+29.73%
$0.86
NVDA
-0.81%
$181.16
PLUG
-8.23%
$3.12
BITF
-9.83%
$4.49
ADAP
-17.62%
$0.04
BURU
-14.84%
$0.28
T
-0.26%
$26.03
AIRE
+61.36%
$0.72
NVTS
+16.64%
$17.10
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
BTG
-9.12%
$5.18
DNN
-6.99%
$2.72
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.27%
$13.38
DVLT
0.00%
$2.41
IBIO
+24.30%
$1.11
RIG
+0.45%
$3.30
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
RXRX
-8.53%
$6.11
SOFI
+0.24%
$28.75
ETHD
-0.53%
$3.73
ABEV
-2.42%
$2.21
TSLA
-1.07%
$442.60
RF
+1.22%
$24.35
ABAT
+38.55%
$6.72
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.84%
$11.40
IONZ
+1.48%
$4.11
GM
+14.84%
$66.61
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
LAES
-8.46%
$5.93
VALE
-1.22%
$11.26
BTBT
-8.29%
$3.87
NEHC
+23.95%
$5.64
PFE
+0.64%
$24.85
QBTS
-6.36%
$32.21
IREN
-6.79%
$55.19
DCGO
+24.16%
$1.49
RMBL
+60.50%
$3.21
HAL
+11.53%
$25.23
MARA
-3.18%
$20.07
BBD
-2.21%
$3.30
AAL
+1.47%
$12.35
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
DFLI
-3.96%
$1.21
AAPL
+0.38%
$263.26
CLSK
-7.62%
$18.84
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.45%
$51.94
KO
+4.10%
$71.25
ORCL
-4.85%
$277.18
SNAP
+1.68%
$7.86
PBR
-1.06%
$11.56
AMC
+3.61%
$2.87
NOK
-1.92%
$5.60
SMR
-13.23%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
ONDS
-7.46%
$7.19
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.78%
$152.08
CJET
-20.45%
$0.08
RIVN
+0.91%
$13.20
PLTR
-0.04%
$181.51
GOOG
-2.20%
$251.34
EPWK
-8.71%
$0.07
ETWO
0.00%
$3.30
APLD
-9.35%
$32.54
IONQ
-0.71%
$59.51
BULL
-2.96%
$11.14
RGTZ
+15.11%
$15.61
WTO
+2.93%
$0.06
MSN
+70.10%
$0.81
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.